Fredrik Conradi Schreuder
Presidente en RespiNor AS .
Perfil
Fredrik Conradi Schreuder is currently the Chairman at RespiNor AS and the Director at NeoRad AS.
He previously held positions as the Chairman at Algeta ASA and as the Senior Vice President at Hafslund Nycomed AS.
Cargos activos de Fredrik Conradi Schreuder
| Empresas | Cargo | Inicio |
|---|---|---|
NeoRad AS
 NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Director/Miembro de la Junta | - |
RespiNor AS
 RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Presidente | - |
Antiguos cargos conocidos de Fredrik Conradi Schreuder.
| Empresas | Cargo | Fin |
|---|---|---|
| ALGETA ASA | Presidente | - |
| Hafslund Nycomed AS | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
NeoRad AS
NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Health Technology |
| Hafslund Nycomed AS | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
RespiNor AS
RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |
- Bolsa de valores
- Insiders
- Fredrik Conradi Schreuder